505
Views
3
CrossRef citations to date
0
Altmetric
Pearls on Therapy

Transcutaneous electrical nerve stimulation (TENS): a review of applications in dermatology

ORCID Icon, ORCID Icon & ORCID Icon
Pages 846-849 | Received 27 Jun 2019, Accepted 13 Aug 2019, Published online: 29 Aug 2019

References

  • Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971–979.
  • Johnson M. Transcutaneous electrical nerve stimulation: mechanisms, clinical application and evidence. Rev Pain. 2007;1:7–11.
  • Vance CG, Dailey DL, Rakel BA, et al. Using TENS for pain control: the state of the evidence. Pain Manage. 2014;4:197–209.
  • Halldin CB, Paoli J, Sandberg C, et al. Transcutaneous electrical nerve stimulation for pain relief during photodynamic therapy of actinic keratoses. Acta Derm Venereol. 2008;88:311–313.
  • Barbarisi M, Pace MC, Passavanti MB, et al. Pregabalin and transcutaneous electrical nerve stimulation for postherpetic neuralgia treatment. Clin J Pain. 2010;26:567–572.
  • Kolšek M. TENS – an alternative to antiviral drugs for acute herpes zoster treatment and postherpetic neuralgia prevention. Swiss Med Wkly. 2012;141:w13229.
  • Stepanović A, Kolšek M, Kersnik J, et al. Prevention of post-herpetic neuralgia using transcutaneous electrical nerve stimulation. Wien Klin Wochenschr. 2015;127:369–374.
  • Tang WY, Chan LY, Lo KK, et al. Evaluation on the antipruritic role of transcutaneous electrical nerve stimulation in the treatment of pruritic dermatoses. Dermatology. 1999;199:237–241.
  • Mohammad Ali BM, Hegab DS, El Saadany HM. Use of transcutaneous electrical nerve stimulation for chronic pruritus. Dermatol Ther. 2015;28:210–215.
  • Yüksek J, Sezer E, Aksu M, et al. Transcutaneous electrical nerve stimulation for reduction of pruritus in macular amyloidosis and lichen simplex. J Dermatol. 2011;38:546–552.
  • Waked I, Ibrahim Z, Elgohary H. Does transcutaneous electrical nerve stimulation have an antipruritic effect in lichen planus? A randomized clinical trial. Clin Exp Dermatol. 2019;44:252–256.
  • Thakral G, Lafontaine J, Najafi B, et al. Electrical stimulation to accelerate wound healing. Diabet Foot Ankle. 2013;4.
  • Clover AJ, McCarthy MJ, Hodgkinson K, et al. Noninvasive augmentation of microvessel number in patients with peripheral vascular disease. J Vasc Surg. 2003;38:1309–1312.
  • Cramp AF, Gilsenan C, Lowe AS, et al. The effect of high- and low-frequency transcutaneous electrical nerve stimulation upon cutaneous blood flow and skin temperature in healthy subjects. Clin Physiol. 2000;20:150–157.
  • Griffin M, Nicolaides AN, Bond D, et al. The efficacy of a new stimulation technology to increase venous flow and prevent venous stasis. Eur J Vasc Endovasc Surg. 2010;40:766–771.
  • Greaves MW. Recent advances in pathophysiology and current management of itch. Ann Acad Med Singapore. 2007;36:788–792.
  • Whitaker C. The use of TENS for pruritus relief in the burns patient: an individual case report. J Burn Care Rehabil. 2001;22:274–276.
  • Dittmar D, Dahlin J, Persson C, et al. Allergic contact dermatitis caused by acrylic acid used in transcutaneous electrical nervous stimulation. Contact Derm. 2017;77:409–412.
  • Marren P, de Berker D, Powell S. Methacrylate sensitivity and transcutaneous electrical nerve stimulation (TENS). Contact Derm. 1991;25:190–191.
  • Weber-Muller F, Reichert-Penetrat S, Schmutz JL, et al. [Contact dermatitis from polyacrylate in TENS electrode]. Ann Dermatol Venereol. 2004;131:478–480.
  • Llamas M, Santiago D, Navarro R, et al. Unusual allergic contact dermatitis produced by a transcutaneous electrical nerve stimulator. Contact Derm. 2010;62:189–190.
  • Zugerman C. Dermatitis from transcutaneous electric nerve stimulation. J Am Acad Dermatol. 1982;6:936–939.
  • Dwyer CM, Chapman RS, Forsyth A. Allergic contact dermatitis from TENS gel. Contact Derm. 1994;30:305.
  • Corazza M, Maranini C, Bacilieri S, et al. Accelerated allergic contact dermatitis to a transcutaneous electrical nerve stimulation device. Dermatology. 1999;199:281.
  • Bolge SC, Goren A, Tandon N. Reasons for discontinuation of subcutaneous biologic therapy in the treatment of rheumatoid arthritis: a patient perspective. Patient Prefer Adher. 2015;9:121–131.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.